PATENT CLAIM ANALYSIS

Application Number: 15752765
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["424", "093100"]

Abstract:
The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as burns or ulcers or the treatment of inflammatory conditions. Optionally, products may be used in combination with further drugs including antimicrobial or antidiabetic agents.

Claim (Index 14):
The composition according to  claim 12 , further comprising a substance selected from the group consisting of:\n an antimicrobial agent; an antidiabetic agent; mRNA or miRNA antagonists against mRNAs or miRNAs over expressed in chronic, non-healing wounds; growth factors selected from the group consisting of PDGF, FGF-2, VEGF-A, -B, -C, -D, GM-CSF, SDF-1alpha, IL1-beta and peptides derived from these growth factors; and inhibitors of enzymes being involved in cortisol synthesis, optionally selected from the group consisting of CYP11B1 overexpressed in chronic wounds, Prolyl-4-hydroxylase, elastase, GSK3\u03b2 phosphorylation and Cx43.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.40426
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15080991', '15455684', '15827539', '15455575', '15647688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6958225025521285
- 35 USC 102 Novelty (BERT): 0.5090208069980353
- Combined Prediction Score: 0.6771423329967192
- Mean Citation Score: 213.13589
- Max Citation Score: 218.5444
- Similarity Product: 123.85925493590833

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test